Drug firm Dr Reddy's Laboratories on Wednesday said its consolidated net profit has gone up 25.38 per cent to Rs 262.74 crore for the first quarter ended June 30, over the same period previous financial year.
The company had a net profit of Rs 209.55 crore in the same period previous year, Dr Reddy's Laboratories said in a filing to the Bombay Stock Exchange (BSE).
The company's net income from sales and services stood at Rs 1,978.32 crore for the reviewed quarter, against Rs 1,683.13 crore for the same period last year.
On a standalone basis, the company reported a net profit of Rs 454.05 crore for the quarter ended June 30, compared to Rs 244.48 crore in the same period previous year.
The company's net sales stood at Rs 1,675.71 crore for the first quarter on a standalone basis, against Rs 1,256.22 crore last year.
During the quarter, the company launched 39 new generic products, filed 31 new product registrations and nine drug master files globally, it said.